|

Irinotecan Hydrochloride Liposome Clinical Trials

3 actively recruiting trials

▲ +2 trials since July 2026

Pipeline

Phase 2: 1Phase 3: 2

Top Sponsors

  • Sichuan Baili Pharmaceutical Co., Ltd.2
  • Fudan University1

Indications

  • Cancer3
  • Biliary Tract Cancer2
  • Locally Recurrent Rectal Cancer1

Other3 trials

A Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally Advanced or Metastatic Biliary Tract Cancer After Failure of Platinum-based Chemotherapy(PANKU-BTC01)
Phase 3
A Study of BL-M07D1 Versus Physician's Choice of Chemotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Biliary Tract Cancer After Platinum-containing Chemotherapy Failure
Phase 3
Hypofractionated Radiotherapy Combined With NALIRIF, PD-1 Antibody in Locally Recurrent Rectal Cancer(NOVELTY-R)
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.